![]() |
|
|
Vol. 293, Issue 1, 24-32, April 2000
Novartis Pharma AG, Experimental Toxicology, Basel, Switzerland
(S.G., E.P., A.W.)
The immunosuppressive cyclosporine A derivative,
O-hydroxyethyl-D(Ser)8-cyclosporine
(SDZ IMM 125), was examined for its ability to induce apoptosis in rat
hepatocytes cultured for 4 or 20 h. Four hours after SDZ IMM 125 treatment, chromatin condensation and fragmentation, and the number of
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end
labeled and Annexin V-positive cells increased dose dependently without
any observable lactate dehydrogenase leakage. The activity of the
cysteine protease, caspase-3, was increased, but not that of caspase-1
and -6. The specific caspase-3 inhibitor, Ac-Asp-Glu-Val-Asp-aldehyde,
inhibited caspase-3 activation and attenuated SDZ IMM 125-induced
apoptosis and lactate dehydrogenase leakage. After 20 h of SDZ IMM
125 incubation, the parameters of apoptosis were further increased.
Decreased mitochondrial membrane potential (measured by rhodamine 123 uptake) and cytochrome c release went in parallel with
ultrastructural mitochondrial changes, and might be regarded as early
events that trigger the apoptotic cascade. Transmission electron
microscopy showed cytoplasmic blebbing after 4 h of SDZ IMM 125 incubation. As observed by transmission electron microscopy, treatment
with SDZ IMM 125 resulted in an increase in the number of necrotic
cells after 20 h, but not after 4 h. Our findings
suggest that in rat hepatocyte cultures, SDZ IMM 125 is a specific
inducer of apoptosis after short-term incubation, and this overlaps
with necrosis after longer treatment periods. It is very likely that
the necrosis occurring later is the result of the early apoptotic events.